Table 4.
Correlations between serum ferritin and patient characteristics.
| Variable | Correlation coefficients | p-value | |
|---|---|---|---|
| Clinicopathological factors | |||
| ECOG-PS | 0 / 1 / 2 / 3 / 4 | 0.291 | 0.001 |
| BMI (kg/m2) | <18.5 / 18.5-22.9 / ≥23 | -0.022 | 0.812 |
| Liver Metastasis | No / Yes | 0.122 | 0.183 |
| Prior Surgery | No / Yes | 0.083 | 0.368 |
| Prior Chemotherapy | None / 1st line / 2nd line / ≥3rd line | 0.167 | 0.068 |
| Prior Radiotherapy | No / Yes | 0.029 | 0.757 |
| Laboratory factors | |||
| CEA (ng/mL) | ≤5 / >5 | 0.033 | 0.728 |
| CA19-9 (U/mL) | ≤27 / >27 | -0.028 | 0.782 |
| Hb (g/dL) | <12 / ≥12 | 0.006 | 0.952 |
| Albumin (g/dL) | <3.5 / ≥3.5 | -0.170 | 0.064 |
| CRP (mg/L) | <10.0 / ≥10.0 | 0.349 | 0.000 |
| PLT (× 103/μL) | <400 / ≥400 | 0.037 | 0.688 |
| WBC (× 103/μL) | <10.0 / ≥10.0 | 0.197 | 0.031 |
| ANC (cells/μL) | ≤4336.0 / >4336.0 | 0.158 | 0.085 |
| ALC (cells/μL) | ≤1291.1 / >1291.1 | -0.158 | 0.085 |
| AMC (cells/μL) | ≤413.3 / >413.3 | 0.290 | 0.001 |
ECOG-PS = Eastern Cooperative Oncology Group performance status; BMI = body mass index; CEA = carcinoembryonic antigen; CA19-9 = carbohydrate antigen 19-9; Hb = hemoglobin; CRP = C-reactive protein; PLT = platelets; WBC = white blood cell; ANC = absolute neutrophil count; ALC = absolute lymphocyte count; AMC = absolute monocyte count.